Exploring the Relationship Between Suicidality and Persistent Negative Symptoms Following a First Episode of Psychosis.

first-episode psychosis idiopathic negative symptoms secondary negative symptoms suicide

Journal

Schizophrenia bulletin
ISSN: 1745-1701
Titre abrégé: Schizophr Bull
Pays: United States
ID NLM: 0236760

Informations de publication

Date de publication:
17 Oct 2023
Historique:
medline: 17 10 2023
pubmed: 17 10 2023
entrez: 17 10 2023
Statut: aheadofprint

Résumé

Suicide is a leading cause of death in first-episode psychosis (FEP), with an elevated risk during the first year following illness onset. The association between negative symptoms and suicidality remains contentious. Some studies suggest that negative symptoms may be associated with lower suicidality, while others fail to find an association between the two. No previous studies have specifically investigated suicidality in Persistent Negative Symptoms (PNS) and its associated subgroups. In a large cohort of FEP patients (n = 515) from an early intervention service, we investigated suicidality in those with PNS, secondary PNS (ie, sPNS; PNS with clinical-level positive, depressive, or extrapyramidal symptoms), and non-PNS (all other patients) over 24 months. Patients were categorized into PNS groups based on symptoms from month 6 to month 12, and suicidality was evaluated using the Brief Psychiatric Rating Scale (BPRS). Covarying for age and sex, we found that sPNS had higher suicidality relative to PNS and non-PNS throughout the 24-month period, but PNS and non-PNS did not differ. These differences were maintained after adjusting for depressive symptoms. We observed that PNS did not significantly differ from non-PNS. However, we identified sPNS as a group with elevated suicidality above and beyond depression, suggesting that sPNS would benefit from targeted intervention and that PNS categorization identifies a subgroup for whom negative symptoms are not associated with lower suicidality.

Sections du résumé

BACKGROUND AND HYPOTHESIS OBJECTIVE
Suicide is a leading cause of death in first-episode psychosis (FEP), with an elevated risk during the first year following illness onset. The association between negative symptoms and suicidality remains contentious. Some studies suggest that negative symptoms may be associated with lower suicidality, while others fail to find an association between the two. No previous studies have specifically investigated suicidality in Persistent Negative Symptoms (PNS) and its associated subgroups.
STUDY DESIGN METHODS
In a large cohort of FEP patients (n = 515) from an early intervention service, we investigated suicidality in those with PNS, secondary PNS (ie, sPNS; PNS with clinical-level positive, depressive, or extrapyramidal symptoms), and non-PNS (all other patients) over 24 months. Patients were categorized into PNS groups based on symptoms from month 6 to month 12, and suicidality was evaluated using the Brief Psychiatric Rating Scale (BPRS).
STUDY RESULTS RESULTS
Covarying for age and sex, we found that sPNS had higher suicidality relative to PNS and non-PNS throughout the 24-month period, but PNS and non-PNS did not differ. These differences were maintained after adjusting for depressive symptoms.
CONCLUSION CONCLUSIONS
We observed that PNS did not significantly differ from non-PNS. However, we identified sPNS as a group with elevated suicidality above and beyond depression, suggesting that sPNS would benefit from targeted intervention and that PNS categorization identifies a subgroup for whom negative symptoms are not associated with lower suicidality.

Identifiants

pubmed: 37847817
pii: 7320163
doi: 10.1093/schbul/sbad146
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : 68961
Pays : Canada

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Joseph Ghanem (J)

DouglasMental Health University Institute, McGill University, Montreal, Canada.
Department of Psychology, McGill University, Montreal, Canada.

Massimiliano Orri (M)

DouglasMental Health University Institute, McGill University, Montreal, Canada.
Department of Psychiatry, McGill University, Montreal, Canada.

Laura Moro (L)

DouglasMental Health University Institute, McGill University, Montreal, Canada.
Department of Psychology, Université de Montreal, Montreal, Canada.

Katie M Lavigne (KM)

DouglasMental Health University Institute, McGill University, Montreal, Canada.
Department of Psychiatry, McGill University, Montreal, Canada.
McGill Centre for Integrative Neuroscience, Montreal Neurological Institute, McGill University, Montreal, Canada.

Delphine Raucher-Chéné (D)

DouglasMental Health University Institute, McGill University, Montreal, Canada.
Department of Psychiatry, McGill University, Montreal, Canada.

Ashok Malla (A)

DouglasMental Health University Institute, McGill University, Montreal, Canada.
Department of Psychiatry, McGill University, Montreal, Canada.
Prevention and Early Intervention Program for Psychosis, Douglas Mental Health University Institute, Montreal, Canada.

Ridha Joober (R)

DouglasMental Health University Institute, McGill University, Montreal, Canada.
Department of Psychiatry, McGill University, Montreal, Canada.
Prevention and Early Intervention Program for Psychosis, Douglas Mental Health University Institute, Montreal, Canada.

Martin Lepage (M)

DouglasMental Health University Institute, McGill University, Montreal, Canada.
Department of Psychology, McGill University, Montreal, Canada.
Department of Psychiatry, McGill University, Montreal, Canada.
Prevention and Early Intervention Program for Psychosis, Douglas Mental Health University Institute, Montreal, Canada.

Classifications MeSH